Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

139

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A02BC01	OMEPRAL	G	Omeprazole - 40mg	40mg	Capsule, delayed release	499,142 L.L
C10AA05	LIPONORM	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	1,491,665 L.L
A02BC01	RISEK	G	Omeprazole - 40mg	40mg	Capsule, enteric coated	522,755 L.L
C10AA05	LORVAST	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	1,253,805 L.L
A02BC01	ESELAN	G	Omeprazole (sodium) - 40mg	40mg	Injectable lyophilised powder for solution	2,073,549 L.L
C10AA05	ORBALIP	G	Atorvastatin (calcium) - 40mg	40mg	Tablet	1,405,275 L.L
A02BC01	IPPROTON	G	Omeprazole - 40mg	40mg	Injectable lyophilised powder	6,533,762 L.L
C10AA05	ORVASTA	G	Atorvastatin - 40mg	40mg	Tablet, film coated	1,170,487 L.L
A02BC01	LOZICARE	G	Omeprazole - 40mg	40mg	Injectable powder for solution	12,446,972 L.L
C10AA05	TARDELIP	G	Atorvastatin - 40mg	40mg	Tablet, film coated	1,055,876 L.L
A02BC01	OMEPRAZOLE ARROW	G	Omeprazole - 40mg	40mg	Injectable powder for solution	454,219 L.L
C10AA05	TARDEN	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	1,055,876 L.L
A02BC01	OMEPRAZOLE VIANEX	G	Omeprazole (sodium) - 40mg	40mg	Injectable powder for solution+diluent	467,657 L.L
C09CA03	VIOSTAN 40	G	Valsartan - 40mg	40mg	Tablet, film coated	526,786 L.L
C10AA05	TORVACOL 40	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, coated	2,363,819 L.L
A02BC01	OMEPRAZOLE-ORBUCELL	G	Omeprazole (sodium) - 40mg	40mg	Injectable solution	3,839,550 L.L
C10AA05	TORVALIP 40	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	1,164,664 L.L
A02BC01	RISEK	G	Omeprazole (sodium) - 40mg	40mg	Injectable lyophilised powder for solution	592,635 L.L
C10AA05	TOVAST	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	2,412,197 L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	895,895 L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	5,916,747 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,104,639 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	581,884 L.L
A02BC02	PANTO TAD	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, gastroresistant	470,345 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	771,366 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	1,381,470 L.L
A02BC02	PANTOVER	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	739,113 L.L
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	727,019 L.L
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,252,461 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	463,050 L.L

...

139

...